zynyz - retifanlimab - dlwr injection
(Retifanlimab-Dlwr)Incyte Corporation
Usage: ZYNYZ treats squamous cell carcinoma of the anal canal (SCAC) — with carboplatin and paclitaxel as first-line therapy, or as a single agent after platinum-based chemotherapy. Also indicated for metastatic or recurrent locally advanced Merkel cell carcinoma (MCC) in adults.